Last reviewed · How we verify

NCT07441798

Efficacy and Safety of 6Degrees MyMove Interactive Virtual Reality Compared to Passive Virtual Reality in Subacute Stroke and Traumatic Brain Injury Rehabilitation: A Randomized Controlled Trial

Not yet recruiting NA Last updated 2 March 2026
What this trial tests

NA trial testing MyMove/VR system in TBI Traumatic Brain Injury in 60 participants. Not yet recruiting.

Timeline
18 March 2026
Primary endpoint
31 May 2028
31 December 2028

Quick facts

Lead sponsorReuth Rehabilitation Hospital
PhaseNA
StatusNot yet recruiting
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingtriple
Primary purposetreatment
Enrollment60
Start date18 March 2026
Primary completion31 May 2028
Estimated completion31 December 2028
Sites1 location across Israel

Drugs / interventions tested

Conditions studied

Sponsor

Reuth Rehabilitation Hospital

Who can join

40 and older, any sex, with TBI Traumatic Brain Injury or CVA (Cerebrovascular Accident). Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Stroke and traumatic brain injury frequently result in persistent upper and lower limb motor impairment. While conventional rehabilitation improves outcomes, patient adherence and training intensity remain limiting factors. Immersive virtual reality (VR)-based therapy may enhance neuroplasticity by delivering high-intensity, task-oriented motor practice with enriched sensory feedback. This randomized controlled trial evaluates the efficacy and safety of the 6Degrees MyMove interactive VR system compared to passive VR exposure in individuals undergoing subacute inpatient rehabilitation after stroke or traumatic brain injury. Sixty participants will be randomized 1:1 to receive either interactive VR-based motor training or passive VR viewing, in addition to standard rehabilitation care, three times weekly for eight weeks. The primary objective is to determine whether interactive VR leads to greater improvement in motor function compared to passive VR. Secondary outcomes include dexterity, gait speed, functional independence, psychological status, adherence, usability, and safety.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of MyMove/VR system

Trials testing the same drug.

Other recruiting trials for TBI Traumatic Brain Injury

Currently open trials in the same condition.

Other Reuth Rehabilitation Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07441798.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing